|
業務類別
|
Biotechnology |
|
業務概覽
|
Jasper Therapeutics Inc is a clinical-stage biotechnology company dedicated to enabling cures through hematopoietic stem cell therapy. It is focused on the development and commercialization of safer and more effective conditioning agents and stem cell engineering to allow for expanded use of stem cell transplantation and ex vivo gene therapy. |
| 公司地址
| 2200 Bridge Parkway, Suite 102, Redwood, CA, USA, 94065 |
| 電話號碼
| +1 650 549-1400 |
| 傳真號碼
| -- |
| 公司網頁
| https://www.jaspertherapeutics.com |
| 員工數量
| 64 |
| Mr. Herbert C. Cross |
Corporate Secretary, Chief Financial Officer and Principal Accounting Officer |
美元 476.10K |
19/05/2025 |
| Mr. Jeet Mahal |
Chief Executive Officer and President |
美元 481.30K |
07/01/2026 |
|
|
| Mr. Kurt von Emster, C.F.A. |
Independent Director |
19/05/2025 |
| Mr. Vishal Kapoor |
Independent Director |
19/05/2025 |
| Mr. Thomas G. Wiggans |
Executive Chairman of the Board |
07/01/2026 |
| Dr. Scott C. Brun, M.D. |
Independent Director |
19/05/2025 |
| Dr. Svetlana Lucas, PhD |
Independent Director |
19/05/2025 |
| Dr. Judith Shizuru, M.D.,PhD |
Director |
19/05/2025 |
| Mr. Christian W. Nolet |
Independent Director |
19/05/2025 |
|
|
|
|
